SB1178: Buprenorphine without naloxone; prescription limitation.


VIRGINIA ACTS OF ASSEMBLY -- CHAPTER
An Act to amend the Code of Virginia by adding a section numbered 54.1-3408.4, relating to prescription of buprenorphine without naloxone; limitation.
[S 1178]
Approved

 

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 54.1-3408.4 as follows:

§ 54.1-3408.4. Prescription of buprenorphine without naloxone; limitation.

Prescriptions for products containing buprenorphine without naloxone shall be issued only (i) for patients who are pregnant, (ii) when converting a patient from methadone to buprenorphine containing naloxone for a period not to exceed seven days, or (iii) as permitted by regulations of the Board of Medicine, the Board of Nursing, or the Board of Veterinary Medicine.

2. That the provisions of this act shall expire on July 1, 2022.


VIRGINIA ACTS OF ASSEMBLY -- CHAPTER
An Act to amend the Code of Virginia by adding a section numbered 54.1-3408.4, relating to prescription of buprenorphine without naloxone; limitation.
[S 1178]
Approved

 

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 54.1-3408.4 as follows:

§ 54.1-3408.4. Prescription of buprenorphine without naloxone; limitation.

Prescriptions for products containing buprenorphine without naloxone shall be issued only (i) for patients who are pregnant, (ii) when converting a patient from methadone to buprenorphine containing naloxone for a period not to exceed seven days, or (iii) as permitted by regulations of the Board of Medicine or the Board of Nursing.

2. That an emergency exists and this act is in force from its passage.

3. That the provisions of this act shall expire on July 1, 2022.


SENATE BILL NO. 1178
AMENDMENT IN THE NATURE OF A SUBSTITUTE
(Proposed by the House Committee on Health, Welfare and Institutions
on February 14, 2017)
(Patron Prior to Substitute--Senator Chafin)
A BILL to amend the Code of Virginia by adding a section numbered 54.1-3408.4, relating to prescription of buprenorphine without naloxone; limitation.

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 54.1-3408.4 as follows:

§ 54.1-3408.4. Prescription of buprenorphine without naloxone; limitation.

Prescriptions for products containing buprenorphine without naloxone shall be issued only (i) for patients who are pregnant, (ii) when converting a patient from methadone to buprenorphine containing naloxone for a period not to exceed seven days, or (iii) as permitted by regulations of the Board of Medicine or the Board of Nursing.

2. That an emergency exists and this act is in force from its passage.

3. That the provisions of this act shall expire on July 1, 2022.


SENATE BILL NO. 1178
Senate Amendments in [ ] -- January 23, 2017
A BILL to amend the Code of Virginia by adding a section numbered 54.1-3408.4, relating to prescription of buprenorphine without naloxone; limitation.
Patron Prior to Engrossment--Senator Chafin

Referred to Committee on Education and Health

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 54.1-3408.4 as follows:

§ 54.1-3408.4. Prescription of buprenorphine without naloxone; limitation.

Prescriptions for buprenorphine mono or products containing buprenorphine without naloxone shall be issued only for a patient who is pregnant.

 [ 2. That the provisions of this act shall expire on July 1, 2022. ]

SENATE BILL NO. 1178

Offered January 11, 2017
Prefiled January 10, 2017
A BILL to amend the Code of Virginia by adding a section numbered 54.1-3408.4, relating to prescription of buprenorphine without naloxone; limitation.
Patron-- Chafin

Referred to Committee on Education and Health

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 54.1-3408.4 as follows:

§ 54.1-3408.4. Prescription of buprenorphine without naloxone; limitation.

Prescriptions for buprenorphine mono or products containing buprenorphine without naloxone shall be issued only for a patient who is pregnant.